Emerging frontiers of responsive nanomaterials in drug delivery systems: from design to clinical translation

Responsive nanomaterials have emerged as advanced platforms in modern therapeutics by enabling controlled drug release in response to specific internal and external stimuli. This review, “Emerging Frontiers of Responsive Nanomaterials in Drug Delivery Systems: From Design to Clinical Translation,” summarizes recent advances that highlight the importance of responsiveness in overcoming challenges such as heterogeneous disease microenvironments, off-target toxicity, and limited therapeutic control. Unlike conventional nanocarriers that rely mainly on passive targeting and continuous drug release, stimuli-responsive systems allow on-demand, site-specific, and temporally regulated drug delivery, improving efficacy while minimizing systemic side effects. These nanocarriers respond to biochemical cues, including pH, redox conditions, enzymes, and hypoxia, as well as physical triggers such as temperature, light, magnetic fields, and ultrasound. The review discusses major classes of responsive nanomaterials, including polymeric, lipid-based, inorganic, and hybrid nanoparticles, with emphasis on design strategies, stimulus-dependent release mechanisms, and disease-specific applications. Key challenges related to scalability, safety, reproducibility, and regulatory translation are addressed alongside emerging directions such as multi-stimuli-responsive systems, theranostics, AI-assisted nanodesign, and personalized nanomedicine.